Supplementary Figure S7. Superior anti-tumor effect of meso^FAP compared to the combination of meso-CAR and FAP-CAR or meso^CD19.
No takes yet. Share an insight, caveat, or question.
Wehrli et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: